SEARCH

SEARCH BY CITATION

References

  • Brindle RJ, Nunn PP, Githui W et al. (1993) Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. American Review of Respiratory Disease 147, 958961.
  • Bwire R, Borgdorff MW, Sticht-Groh V et al. (1999) Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. East African Medical Journal 76, 307313.
  • Ellner JJ (1997) Review: the immune response in human tuberculosis – implications for tuberculosis control. Journal of Infectious Diseases 176, 13511359.
  • Fawzi WW, Msamanga GI, Spiegelman D et al. (2004) A randomized trial of multivitamin supplements and HIV disease progression and mortality. New England Journal of Medicine 351, 2332.
  • Githui W, Kitui F, Juma ES et al. (1993) A comparative study on the reliability of the fluorescence microscopy and Ziehl–Neelsen method in the diagnosis of pulmonary tuberculosis. East African Medical Journal 70, 263266.
  • Heifets LB & Good RC (1994) Current laboratory methods for the diagnosis of tuberculosis. In: Tuberculosis: Pathogenesis, Protection and Control (ed. BloomBR) American Society for Microbiology, Washington, DC, pp. 85110.
  • Kang'ombe C, Harries AD, Banda H et al. (2000) High mortality rates in tuberculosis patients in Zomba Hospital, Malawi, during 32 months of follow-up. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 305309.
  • Karyadi E, Schultink W, Nelwan RH et al. (2000) Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia. Journal of Nutrition 130, 29532958.
  • Karyadi E, West CE, Schultink W et al. (2002) A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. American Journal of Clinical Nutrition 75, 720727.
  • Kassim S, Sassan-Morokro M, Ackah A et al. (1995) Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa. AIDS 9, 11851191.
  • van Lettow M, Fawzi WW & Semba RD (2003) Triple trouble: the role of malnutrition in tuberculosis and human immunodeficiency virus co-infection. Nutrition Reviews 61, 8190.
  • Liu Z, Shilkret KL & Ellis HM (1999) Predictors of sputum culture conversion among patients with tuberculosis in the era of tuberculosis resurgence. Archives of Internal Medicine 159, 11101116.
  • Mugusi FM, Rusizoka O, Habib N & Fawzi W (2003) Vitamin A status of patients presenting with pulmonary tuberculosis and asymptomatic HIV-infected individuals, Dar es Salaam, Tanzania. International Journal of Tuberculosis and Lung Disease 7, 804807.
  • Ramarokoto H, Randriamiharisoa H, Rakotoarisaonina A et al. (2002) Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment. International Journal of Tuberculosis and Lung Disease 6, 909912.
  • Ray M, Kumar L & Prasad R (1998) Plasma zinc status in Indian childhood tuberculosis: impact of antituberculosis therapy. International Journal of Tuberculosis and Lung Disease 2, 719725.
  • Rieder HL, Chonde TM, Myking H et al. (1998) The public health service national tuberculosis reference laboratory and the national laboratory network. Minimum requirements, role and operation in a low-income country, International Union Against Tuberculosis and Lung Disease. http://www.iuatld.org/pdf/en/guides_publications/public_health_service.pdf .
  • Rwangabwoba JM, Fischman H & Semba RD (1998) Serum vitamin A levels during tuberculosis and human immunodeficiency virus infection. International Journal of Tuberculosis and Lung Disease 2, 771773.
  • Small PM, Schecter GF, Goodman PC et al. (1991) Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 324, 289294.
  • Telzak EE, Fazal BA, Pollard CL et al. (1997) Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clinical Infectious Diseases 25, 666670.
  • World Health Organization (2003) Treatment of Tuberculosis: Guidelines for National Programmes, Edn. 3. WHO, Geneva.